WP4: Electronic databases and registries

Thank you for your interest. The I-MOVE+ project (2015-2018) is over, and this website will no longer be updated. However, activities to monitor vaccine effectiveness in Europe are ongoing and can be found on the I-MOVE and SpiDnet websites for influenza (coming soon) and pneumococcal vaccines (https://sites.google.com/a/epiconcept.fr/ipd-surveillance/)

The overall aim is to modify and adapt existing protocols (from WP2 and WP3) to use registry-based data for
assessment  of  vaccine  effectiveness  and  impact  against  influenza  and  pneumococcal  disease.  Furthermore,
these  protocols  will  be  applied  in  registry-based  studies  in  order  to  contribute  to  the  deliverables  in  WP2
(influenza vaccines) and WP3 (pneumococcal vaccines). Hence, the work in WP4 will be coordinated with the
work in WP2 and WP3 to agree on a joint interpretation of the outcomes from the various studies.
Finally, the aim is also to provide figures that can contribute to estimation of cost-effectiveness (WP5).

Leader: Statens Serum Institut

Participants:
  • Edinburgh University
  • ISPLN, Navarra, Spain
  • Health Protection Scotland
  • Public Health England
  • NIVEL, the Netherlands
  • RCGP, Enland
  • SSI, Denmark
  • THL, Finland

Access to restricted area for Work Package 4


I-MOVE+ Generic Register-based protocols to measure influenza vaccine effectiveness : 
  • Protocol for register-based studies to measure seasonal influenza vaccine effectiveness against laboratory confirmed influenza in hospitalised patients, including ICU admitted patients, among the elderly  <click to view>
  • Generic Protocol for the register based studies to measure seasonal influenza vaccine effectiveness against laboratory confirmed influenza and pneumonia among elderly in primary care 
    <click here to view>
    (Study site specific protocols are available upon request)
    Ċ
    Marta Valenciano,
    Oct 11, 2018, 3:37 AM
    Ċ
    Marta Valenciano,
    Oct 11, 2018, 3:37 AM